Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists
about
Potentiating effects of GHRH analogs on the response to chemotherapy.Tumor-associated and disease-associated autoantibody repertoires in healthy colostrum and maternal and newborn cord sera.Salinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the β-catenin/TCF complex association via FOXO3a activationDownregulation of Oxytocin Receptor Decreases the Length of Projections Stimulated by Retinoic Acid in the U-87MG Cells.
P2860
Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists
@en
Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists.
@nl
type
label
Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists
@en
Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists.
@nl
prefLabel
Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists
@en
Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists.
@nl
P2093
P2860
P50
P356
P1476
Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists
@en
P2093
Arumugam R Jayakumar
Irving Vidaurre
Luca Szalontay
Marta Zarandi
Norman L Block
Ren-Zhi Cai
P2860
P304
P356
10.1073/PNAS.1322622111
P407
P577
2013-12-30T00:00:00Z